Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Oct 16;173(2):455–463. doi: 10.1007/s10549-018-4990-9

Table 4.

Performance of the Multivariate Models in the Test Set: areas under the ROC,95% confidence interval, and p-value).

Neoadjuvant Therapy Neoadjuvant Chemotherapy Neoadjuvant Therapy in TN/HER2+
Number of features selected for multivariate modeling 2 7 4
Logistic regression-based classifier 0.658 (0.556—0.760, p = 0.0106) 0.589 (0.484—0.694, p = 0.140) 0.707 (0.582—0.832, p < 0.002)
Support vector machine 0.593 (0.482—0.703, p = 0.136) 0.593 (0.489—0.694, p = 0.127) 0.705 (0.581—0.829, p < 0.002)